In a recent study, researchers identified SHH2 as being significantly associated with AD risk using integrative genomics and blood methylome data analysis.[31] Interestingly, in glutamatergic neurons, we observed an increase in the expression of EPB41L2 and SSH2, 2 genes associated with an increased risk of developing AD. This evidence concerns the gene EPB41L2 and Alzheimer disease.